Peripheral dendritic cells prime T cells that drive tau-mediated neurodegeneration

Dendritic cells in the body's peripheral immune system actively accelerate neurodegeneration through tau pathology, challenging the long-held view of the brain as an immunologically isolated organ. Researchers found that these antigen-presenting cells activate CD8+ cytotoxic T lymphocytes—comprising 60–70% of infiltrating T cells in tau-transgenic brains—via a process called antigen cross-presentation. Genetically ablating conventional type 1 dendritic cells (cDC1s) or disrupting their antigen cross-presentation capacity in tau-bearing mice with APOE4 significantly protected against neurodegeneration and selectively reduced CD8+ T cell accumulation in the brain. Critically, this T cell priming happens outside the central nervous system, in peripheral tissues. For longevity-focused readers, the finding reframes therapeutic strategy: targeting antigen presentation at the body's periphery—before T cells breach the aging blood-brain barrier—may prove more effective than addressing neuroinflammation after infiltration occurs, with direct implications for Alzheimer's and related tauopathies.